Genetic changes associated with relapse in favorable histology Wilms tumor: A Children’s Oncology Group AREN03B2 study

Over the last decade, sequencing of primary tumors has clarified the genetic underpinnings of Wilms tumor but has not affected therapy, outcome, or toxicity. We now sharpen our focus on relapse samples from the umbrella AREN03B2 study. We show that over 40% of relapse samples contain mutations in SI...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadd, Samantha, Huff, Vicki, Skol, Andrew D., Renfro, Lindsay A., Fernandez, Conrad V., Mullen, Elizabeth A., Jones, Corbin D., Hoadley, Katherine A., Yap, Kai Lee, Ramirez, Nilsa C., Aris, Sheena, Phung, Quy H., Perlman, Elizabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244995/
https://www.ncbi.nlm.nih.gov/pubmed/35617957
http://dx.doi.org/10.1016/j.xcrm.2022.100644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244995/
https://www.ncbi.nlm.nih.gov/pubmed/35617957
http://dx.doi.org/10.1016/j.xcrm.2022.100644

Ejemplares similares